Sell the story, not the stock! | KoreSummit MedTech A+ Team

Secondary ATS - Private companies can now TRADE!

This was our #KoreSummit! 

Today you’ve learned from experts how to start your capital raising journey for Medtech, Biotech, and Pharma industries.

RegA+ can benefit your company to raise up to $75 million from non-accredited investors.

#innovation #medtech #rega #regulations #capitalmarkets #privateequity

What is the role of the quarterback inside a private equity an ecosystem? Is it necessary to have a team or you can do it all yourself? How can we raise money compliantly to innovate in such a competitive and quickly growing sector? Peter Daneyko and Stephen Brock throw some insights on these topics and much more as KoreConX and KorePartners prepare for our KoreSummit on June, 23rd.

Cannabis companies also need to raise capital compliantly. With Regulations like RegA+ and RegCF, it is possible to raise up to US$ 75 million from brand advocates and non-accredited investors. Join us to talk about community building, regulations and possibilities, with Jessica Trapani and Brianna Martyn.

Join our CIO, Kiran K. Garimella, and Andrew Bull, Esq., founding partner @ Bull Blockchain Law, LLP to learn more about digital securities, tokens, coins and regulations.

Join Jason Futko, our co-founder and CFO as he welcomes Tim Martinez, from Digital Niche Agency, to talk about investor acquisition. As investors become shareholders that often have some kind of say in the company, it will be important to choose investors that will aid you on your journey to grow your company. But how exactly do you find the right investor for you and your company’s vision?

Join Amanda Grange, our Transfer Agent Specialist, and Matt McNamara, Managing Partner at Assurance Dimensions, to talk about best practices and how to begin your cap table compliantly.

Follow us on LinkedIn https://www.linkedin.com/company/koreconx/

Do you know how #esg has reshaped the market for companies and investors?

Our #KoreTalkX is already on and our second episode is right around the corner. Our CRO Peter Daneyko and Paul Karrlsson-Willis, CEO of JUSTLY Markets, talk about ESG and compliance in raising capital. Companies tend to change a lot since the rise of ESG. And how have investors changed, and what are the strategies to fit this new world?

Securities offered through JUSTLY Markets LLC (www.InvestJUSTLY.com), member of FINRA/SIPC and a wholly-owned subsidiary of Ideanomics

#venturecapital #korepartners #privatecapital #compliance

We got together with David Weild IV, Father of the JOBS Act, to discuss everything that has been accomplished so far.